| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1473-3099(04)01006-0 |
| P698 | PubMed publication ID | 15120347 |
| P50 | author | Alex Wodak | Q4718003 |
| Steffanie Strathdee | Q7606605 | ||
| Mark W. Tyndall | Q51002222 | ||
| Thomas Kerr | Q85344273 | ||
| Evan Wood | Q85344858 | ||
| Catherine Hankins | Q30513822 | ||
| Martin T. Schechter | Q40448698 | ||
| P2093 | author name string | Julio S Montaner | |
| P2860 | cites work | The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users | Q42692167 |
| Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users | Q42692172 | ||
| Impact of HIV infection on mortality in a cohort of injection drug users | Q43798771 | ||
| Reaching the unreached: targeting hidden IDU populations with clean needles via known user groups | Q43851533 | ||
| Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme | Q43937466 | ||
| Drug use and initiation in prison: results from a national prison survey in England and Wales. | Q44242638 | ||
| Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy | Q45710860 | ||
| Harm reduction and needle exchange programmes | Q46165118 | ||
| Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco | Q46211937 | ||
| Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia | Q55924276 | ||
| Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users | Q56225840 | ||
| 'Sending the wrong signal': analysis of print media reportage of the ACT heroin prescription trial proposal, August 1997 | Q56946699 | ||
| A comparison of the new Federal Guidelines regulating supervised injection site research in Canada and the Tri-Council Policy Statement on Ethical Conduct for Research Involving Human Subjects | Q57671815 | ||
| The Impact of a Police Presence on Access to Needle Exchange Programs | Q57671909 | ||
| Fatal Overdose Trends in Major us Cities: 1990–1997 | Q58277442 | ||
| Evaluation der Gassenzimmer I, II und III in Basel | Q61662531 | ||
| Risk factors for shooting gallery use and cessation among intravenous drug users | Q68025744 | ||
| Establishing safe injecting rooms in Australia: attitudes of injecting drug users | Q73213988 | ||
| An outbreak of syphilis in Alabama prisons: correctional health policy and communicable disease control | Q74351474 | ||
| HIV incidence among injecting drug users in New York City syringe-exchange programmes | Q30233828 | ||
| Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective | Q30670433 | ||
| Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. | Q30730194 | ||
| Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. | Q30957144 | ||
| Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico | Q32064492 | ||
| Needle-exchange attendance and health care utilization promote entry into detoxification | Q34506338 | ||
| Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors | Q34511319 | ||
| The war on drugs--a peace proposal | Q34726289 | ||
| Human immunodeficiency virus in correctional facilities: a review | Q34736400 | ||
| Drug injection among street youths in Montreal: predictors of initiation | Q36272972 | ||
| The social determinants of emergency department and hospital use by injection drug users in Canada | Q36274713 | ||
| Outbreak of HIV infection in a Scottish prison | Q36902181 | ||
| Antiretroviral medication use among injection drug users: two potential futures | Q39541745 | ||
| Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney | Q39553799 | ||
| Safety becomes danger: dilemmas of drug-use in public space | Q39584331 | ||
| Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. | Q39650979 | ||
| Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic | Q42595766 | ||
| Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation | Q42667554 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 301-306 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Rationale for evaluating North America's first medically supervised safer-injecting facility | |
| P478 | volume | 4 |
| Q93600303 | Q93600303 |
| Q33912772 | Acceptability of a safer injection facility among injection drug users in San Francisco. |
| Q34221599 | An appeal to humanity: legal victory in favour of North America's only supervised injection facility: Insite |
| Q58126719 | An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation |
| Q37362178 | Assisted injection among people who inject drugs in Thailand |
| Q59546244 | Being realistic about benefits of supervised injecting facilities |
| Q37100669 | CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment |
| Q37525649 | CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults |
| Q36380319 | Canada's highest court unchains injection drug users; implications for harm reduction as standard of healthcare |
| Q24561498 | Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users |
| Q46020901 | Characteristics of injection drug users who participate in drug dealing: implications for drug policy. |
| Q57690454 | Characteristics of young illicit drug injectors who use North America's first medically supervised safer injecting facility |
| Q37377762 | DETERMINANTS OF CUTANEOUS INJECTION-RELATED INFECTIONS AMONG INJECTION DRUG USERS AT AN EMERGENCY DEPARTMENT. |
| Q57153779 | Developing Canada's research base for harm reduction and health equity approaches to HIV prevention and treatment |
| Q33555028 | Displacement of Canada's largest public illicit drug market in response to a police crackdown |
| Q39775956 | Drug-related overdose deaths in British Columbia and Ontario, 1992-2004. |
| Q34690989 | Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study |
| Q57690504 | Factors Associated with Public Injecting Among Users of Vancouver's Supervised Injection Facility |
| Q37032437 | Fighting addiction's death row: British Columbia Supreme Court Justice Ian Pitfield shows a measure of legal courage |
| Q35578532 | HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: implications for prevention, care and treatment |
| Q51908256 | Hepatitis C, illicit drug use and public health: does Canada really have a viable plan? |
| Q38881551 | High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada |
| Q39756368 | Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. |
| Q34315641 | Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study |
| Q35127554 | Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility. |
| Q37114061 | Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors |
| Q35999959 | Injecting drugs in tight spaces: HIV, cocaine and collinearity in the Downtown Eastside, Vancouver, Canada. |
| Q41502073 | Injection drug use cessation and use of North America's first medically supervised safer injecting facility |
| Q24558770 | Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users |
| Q46515344 | Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. |
| Q88646759 | Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk |
| Q24649575 | Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility |
| Q24815445 | Prevalence and correlates of abscesses among a cohort of injection drug users |
| Q51781996 | Prevalence and correlates of cervical cancer screening among injection drug users. |
| Q45130692 | Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making |
| Q34626103 | Public crack cocaine smoking and willingness to use a supervised inhalation facility: implications for street disorder. |
| Q36292105 | Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users. |
| Q57690307 | Recent incarceration and use of a supervised injection facility in Vancouver, Canada |
| Q34178819 | Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. |
| Q34559436 | Safer injection facility use and syringe sharing in injection drug users. |
| Q52289027 | Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. |
| Q47665050 | Social Determinants of HIV/HCV Co-Infection: A case Study from People Who Inject Drugs in Rural Puerto Rico |
| Q92777890 | Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment |
| Q52287975 | Sociodemographic disparities in access to addiction treatment among a cohort of Vancouver injection drug users. |
| Q24673390 | Summary of findings from the evaluation of a pilot medically supervised safer injecting facility |
| Q30234420 | Supervised injection facilities in Canada: past, present, and future |
| Q36272359 | The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions |
| Q37020250 | The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility |
| Q34764625 | The role of safer injection facilities in the response to HIV/AIDS among injection drug users. |
| Q34954262 | The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges. |
| Q37062964 | The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs |
| Q36668343 | Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico |
| Q34403782 | Use of a medically supervised injection facility among street youth |
| Q45069794 | Use of on-site detoxification services co-located with a supervised injection facility |
Search more.